Skip to main content
. 2017 Sep 8;8(45):78978–78988. doi: 10.18632/oncotarget.20741

Figure 1. Expression of H3K27 and its modifiers in medulloblastoma.

Figure 1

Representative selection of immunohistochemical staining for KDM6A, KDM6B, EZH2 and H3K27me3 in MB samples of different subgroups.